Julia Aijun Wang
Insider Reports History
- Location
- Burlington, NC
- Signature
- /s/ Kathryn W. Kyle, Attorney-in-Fact for Julia Aijun Wang
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Julia Aijun Wang:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeiGene, Ltd. | Chief Financial Officer | Ordinary Shares | 426,595 | $88,611,076 | $207.72 | 01 Jul 2024 | Direct |
| LABCORP HOLDINGS INC. | Chief Financial Officer, EVP | Restricted Stock Unit | 4,964 | $1,075,461 | $246.27 | 11 Feb 2026 | Direct |
| LABCORP HOLDINGS INC. | Chief Financial Officer, EVP | Common Stock | 1,817 | $526,799 | $289.89 | 11 Feb 2026 | Direct |
| BeiGene, Ltd. | Chief Financial Officer | American Depositary Shares | 0 | $0 | $143.90 | 01 Jul 2024 | Direct |
| BeiGene, Ltd. | Chief Financial Officer | Share Option (Right to Buy) | 256,659 | 05 Jun 2024 | Direct | ||
| LABCORP HOLDINGS INC. | Chief Financial Officer, EVP | Non-qualified Stock Options | 7,100 | 10 Feb 2026 | Direct |
Insider Reports Filed by Julia Aijun Wang
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LH | LABCORP HOLDINGS INC. | 11 Feb 2026 | 3 | -$71,023 | 4 | Chief Financial Officer, EVP | 13 Feb 2026, 13:16 |
| LH | LABCORP HOLDINGS INC. | 10 Feb 2026 | 2 | $0 | 4 | Chief Financial Officer, EVP | 12 Feb 2026, 15:41 |
| LH | LABCORP HOLDINGS INC. | 06 Feb 2026 | 3 | -$70,409 | 4 | Chief Financial Officer, EVP | 10 Feb 2026, 15:34 |
| LH | LABCORP HOLDINGS INC. | 11 Feb 2025 | 2 | $0 | 4 | Chief Financial Officer, EVP | 13 Feb 2025, 11:18 |
| LH | LABCORP HOLDINGS INC. | 06 Feb 2025 | 3 | -$83,241 | 4 | Chief Financial Officer, EVP | 10 Feb 2025, 09:00 |
| LH | LABCORP HOLDINGS INC. | 02 Dec 2024 | 2 | $0 | 4 | Chief Financial Officer, EVP | 04 Dec 2024, 10:05 |
| LH | LABCORP HOLDINGS INC. | 02 Dec 2024 | 0 | $0 | 3 | Chief Financial Officer, EVP | 03 Dec 2024, 09:11 |
| ONC | BeiGene, Ltd. | 01 Jul 2024 | 1 | -$67,919 | 4 | Chief Financial Officer | 03 Jul 2024, 17:05 |
| ONC | BeiGene, Ltd. | 24 Jun 2024 | 1 | -$139,938 | 4 | Chief Financial Officer | 26 Jun 2024, 17:26 |
| ONC | BeiGene, Ltd. | 17 Jun 2024 | 4 | -$145,678 | 4 | Chief Financial Officer | 20 Jun 2024, 17:26 |
| ONC | BeiGene, Ltd. | 05 Jun 2024 | 2 | $0 | 4 | Chief Financial Officer | 07 Jun 2024, 16:54 |
| ONC | BeiGene, Ltd. | 29 Feb 2024 | 1 | -$66,331 | 4 | Chief Financial Officer | 04 Mar 2024, 17:22 |
| ONC | BeiGene, Ltd. | 03 Jul 2023 | 1 | -$84,747 | 4 | Chief Financial Officer | 06 Jul 2023, 17:02 |
| ONC | BeiGene, Ltd. | 23 Jun 2023 | 1 | -$153,594 | 4 | Chief Financial Officer | 27 Jun 2023, 17:22 |
| ONC | BeiGene, Ltd. | 15 Jun 2023 | 3 | -$36,583 | 4 | Chief Financial Officer | 20 Jun 2023, 18:51 |
| ONC | BeiGene, Ltd. | 01 Mar 2023 | 1 | -$82,392 | 4 | Chief Financial Officer | 03 Mar 2023, 16:00 |
| ONC | BeiGene, Ltd. | 01 Jul 2022 | 1 | -$50,244 | 4/A | Chief Financial Officer | 18 Jul 2022, 17:22 |
| ONC | BeiGene, Ltd. | 22 Jun 2022 | 2 | $0 | 4 | Chief Financial Officer | 24 Jun 2022, 17:40 |
| ONC | BeiGene, Ltd. | 17 Jun 2022 | 1 | -$21,999 | 4 | Chief Financial Officer | 21 Jun 2022, 17:09 |
| ONC | BeiGene, Ltd. | 28 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 02 Mar 2022, 16:12 |
| ONC | BeiGene, Ltd. | 01 Jul 2021 | 1 | -$107,512 | 4 | Chief Financial Officer | 01 Jul 2021, 16:58 |
| ONC | BeiGene, Ltd. | 30 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 01 Jul 2021, 16:55 |